{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:35:34Z","timestamp":1791646534276,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG078129"],"award-info":[{"award-number":["R01AG078129"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01519-7","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T17:29:30Z","timestamp":1737134970000},"page":"4075-4092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["5-HT2C agonism as a neurotherapeutic for sarcopenia: preclinical proof of concept"],"prefix":"10.1007","volume":"47","author":[{"given":"Nathan R.","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Dashtmian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh B.","family":"Darvishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhuja N.","family":"Ayyagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Viteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-7036","authenticated-orcid":false,"given":"W.","family":"David Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.ajmo.2024.100065","volume":"11","author":"R McGrath","year":"2024","unstructured":"McGrath R, McGrath BM, Al Snih S, et al. Collective weakness and fluidity in weakness status associated with basic self-care limitations in older Americans. Am J Med Open. 2024;11:100065. https:\/\/doi.org\/10.1016\/j.ajmo.2024.100065.","journal-title":"Am J Med Open."},{"issue":"1","key":"1519_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-019-00545-w","volume":"105","author":"C Beaudart","year":"2019","unstructured":"Beaudart C, Rolland Y, Cruz-Jentoft AJ, et al. Assessment of muscle function and physical performance in daily clinical practice: A position paper endorsed by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Calcif Tissue Int. 2019;105(1):1\u201314. https:\/\/doi.org\/10.1007\/s00223-019-00545-w.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1519_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12603-017-0951-y","volume":"22","author":"KA Duchowny","year":"2018","unstructured":"Duchowny KA, Clarke PJ, Peterson MD. Muscle weakness and physical disability in older Americans: Longitudinal findings from the U.S. health and retirement study. J Nutr Health Aging. 2018;22(4):501\u20137. https:\/\/doi.org\/10.1007\/s12603-017-0951-y.","journal-title":"J Nutr Health Aging."},{"key":"1519_CR4","unstructured":"World Health Organization. Ageing and health. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health.\u00a0Accessed 29 Aug 2024."},{"key":"1519_CR5","unstructured":"World population projected to reach 9.8 billion in 2050, and 11.2 billion in 2100. United Nations. Accessed 10\/1\/2024, 2024."},{"issue":"3","key":"1519_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00223-016-0220-9","volume":"100","author":"O Ethgen","year":"2017","unstructured":"Ethgen O, Beaudart C, Buckinx F, Bruy\u00e8re O, Reginster JY. The future prevalence of sarcopenia in Europe: A claim for public health action. Calcif Tissue Int. 2017;100(3):229\u201334. https:\/\/doi.org\/10.1007\/s00223-016-0220-9.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1519_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2105\/ajph.2008.157388","volume":"100","author":"TE Seeman","year":"2010","unstructured":"Seeman TE, Merkin SS, Crimmins EM, Karlamangla AS. Disability trends among older Americans: National health and nutrition examination surveys, 1988\u20131994 and 1999\u20132004. Am J Public Health. 2010;100(1):100\u20137. https:\/\/doi.org\/10.2105\/ajph.2008.157388.","journal-title":"Am J Public Health"},{"issue":"10","key":"1519_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.apmr.2018.01.008","volume":"99","author":"A Garc\u00eda-Hermoso","year":"2018","unstructured":"Garc\u00eda-Hermoso A, Cavero-Redondo I, Ram\u00edrez-V\u00e9lez R, et al. Muscular strength as a predictor of all-cause mortality in an apparently healthy population: a systematic review and meta-analysis of data from approximately 2 million men and women. Arch Phys Med Rehabil. 2018;99(10):2100-2113.e5. https:\/\/doi.org\/10.1016\/j.apmr.2018.01.008.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"1519_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41536-021-00169-5","volume":"6","author":"A Garmany","year":"2021","unstructured":"Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regen Med. 2021;6(1):57. https:\/\/doi.org\/10.1038\/s41536-021-00169-5.","journal-title":"NPJ Regen Med"},{"issue":"3","key":"1519_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4235\/agmr.19.0028","volume":"23","author":"JY Kwak","year":"2019","unstructured":"Kwak JY, Kwon KS. pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia. Ann Geriatr Med Res. 2019;23(3):98\u2013104. https:\/\/doi.org\/10.4235\/agmr.19.0028.","journal-title":"Ann Geriatr Med Res"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"155597","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland Y, Dray C, Vellas B, Barreto PS. Current and investigational medications for the treatment of sarcopenia. Metabolism. 2023;149:155597. https:\/\/doi.org\/10.1016\/j.metabol.2023.155597.","journal-title":"Metabolism"},{"issue":"1","key":"1519_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.12238","volume":"9","author":"M Tieland","year":"2018","unstructured":"Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle. 2018;9(1):3\u201319. https:\/\/doi.org\/10.1002\/jcsm.12238.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Suppl 1","key":"1519_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/gerona\/glad029","volume":"78","author":"BC Clark","year":"2023","unstructured":"Clark BC. Neural mechanisms of age-related loss of muscle performance and physical function. J Gerontol A Biol Sci Med Sci. 2023;78(Suppl 1):8\u201313. https:\/\/doi.org\/10.1093\/gerona\/glad029.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1519_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0166-4328(97)00752-3","volume":"87","author":"J Ashe","year":"1997","unstructured":"Ashe J. Force and the motor cortex. Behav Brain Res. 1997;87(2):255\u201369. https:\/\/doi.org\/10.1016\/s0166-4328(97)00752-3.","journal-title":"Behav Brain Res"},{"issue":"12","key":"1519_CR15","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.clinph.2009.08.009","volume":"120","author":"CJ Heckman","year":"2009","unstructured":"Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J. Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol. 2009;120(12):2040\u201354. https:\/\/doi.org\/10.1016\/j.clinph.2009.08.009.","journal-title":"Clin Neurophysiol"},{"issue":"10","key":"1519_CR16","doi-asserted-by":"publisher","first-page":"a029702","DOI":"10.1101\/cshperspect.a029702","volume":"7","author":"RM Enoka","year":"2017","unstructured":"Enoka RM, Duchateau J. Rate coding and the control of muscle force. Cold Spring Harb Perspect Med. 2017;7(10):a029702. https:\/\/doi.org\/10.1101\/cshperspect.a029702.","journal-title":"Cold Spring Harb Perspect Med."},{"key":"1519_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-023-01123-x","author":"NP Wages","year":"2023","unstructured":"Wages NP, Mousa MH, Clark LA, et al. Reductions in motor unit firing are associated with clinically meaningful leg extensor weakness in older adults. Calcif Tissue Int. 2023. https:\/\/doi.org\/10.1007\/s00223-023-01123-x.","journal-title":"Calcif Tissue Int"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"111647","DOI":"10.1016\/j.mad.2022.111647","volume":"203","author":"LBR Orssatto","year":"2022","unstructured":"Orssatto LBR, Borg DN, Pendrith L, Blazevich AJ, Shield AJ, Trajano GS. Do motoneuron discharge rates slow with aging? A systematic review and meta-analysis. Mech Ageing Dev. 2022;203:111647. https:\/\/doi.org\/10.1016\/j.mad.2022.111647.","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"1519_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/gerona\/glaa157","volume":"76","author":"LA Clark","year":"2021","unstructured":"Clark LA, Manini TM, Wages NP, Simon JE, Russ DW, Clark BC. Reduced neural excitability and activation contribute to clinically meaningful weakness in older adults. J Gerontol A Biol Sci Med Sci. 2021;76(4):692\u2013702. https:\/\/doi.org\/10.1093\/gerona\/glaa157.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1519_CR20","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s11357-021-00478-z","volume":"43","author":"LBR Orssatto","year":"2021","unstructured":"Orssatto LBR, Borg DN, Blazevich AJ, Sakugawa RL, Shield AJ, Trajano GS. Intrinsic motoneuron excitability is reduced in soleus and tibialis anterior of older adults. Geroscience. 2021;43(6):2719\u201335. https:\/\/doi.org\/10.1007\/s11357-021-00478-z.","journal-title":"Geroscience"},{"issue":"3","key":"1519_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/1073858408314986","volume":"14","author":"CJ Heckman","year":"2008","unstructured":"Heckman CJ, Johnson M, Mottram C, Schuster J. Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist. 2008;14(3):264\u201375. https:\/\/doi.org\/10.1177\/1073858408314986.","journal-title":"Neuroscientist"},{"issue":"5","key":"1519_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1152\/jn.1994.71.5.1727","volume":"71","author":"CJ Heckman","year":"1994","unstructured":"Heckman CJ. Computer simulations of the effects of different synaptic input systems on the steady-state input-output structure of the motoneuron pool. J Neurophysiol. 1994;71(5):1727\u201339. https:\/\/doi.org\/10.1152\/jn.1994.71.5.1727.","journal-title":"J Neurophysiol"},{"issue":"9","key":"1519_CR23","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1249\/mss.0000000000003473","volume":"56","author":"G Martino","year":"2024","unstructured":"Martino G, Valli G, Sarto F, Franchi MV, Narici MV, Dev G. Neuromodulatory contribution to muscle force production after short-term unloading and active recovery. Med Sci Sports Exerc. 2024;56(9):1830\u20139. https:\/\/doi.org\/10.1249\/mss.0000000000003473.","journal-title":"Med Sci Sports Exerc."},{"issue":"3","key":"1519_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/jn.00462.2022","volume":"129","author":"LBR Orssatto","year":"2023","unstructured":"Orssatto LBR, Rodrigues P, Mackay K, et al. Intrinsic motor neuron excitability is increased after resistance training in older adults. J Neurophysiol. 2023;129(3):635\u201350. https:\/\/doi.org\/10.1152\/jn.00462.2022.","journal-title":"J Neurophysiol"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"109761","DOI":"10.1016\/j.neuropharm.2023.109761","volume":"242","author":"JR Thorstensen","year":"2024","unstructured":"Thorstensen JR, Henderson TT, Kavanagh JJ. Serotonergic and noradrenergic contributions to motor cortical and spinal motoneuronal excitability in humans. Neuropharmacology. 2024;242:109761. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109761.","journal-title":"Neuropharmacology"},{"issue":"2","key":"1519_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/jn.00774.2010","volume":"105","author":"KC Murray","year":"2011","unstructured":"Murray KC, Stephens MJ, Ballou EW, Heckman CJ, Bennett DJ. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J Neurophysiol. 2011;105(2):731\u201348. https:\/\/doi.org\/10.1152\/jn.00774.2010.","journal-title":"J Neurophysiol"},{"issue":"6","key":"1519_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ana.25105","volume":"82","author":"P Nardelli","year":"2017","unstructured":"Nardelli P, Powers R, Cope TC, Rich MM. Increasing motor neuron excitability to treat weakness in sepsis. Ann Neurol. 2017;82(6):961\u201371. https:\/\/doi.org\/10.1002\/ana.25105.","journal-title":"Ann Neurol"},{"issue":"1","key":"1519_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ejn.16190","volume":"59","author":"TT Henderson","year":"2024","unstructured":"Henderson TT, Taylor JL, Thorstensen JR, Kavanagh JJ. Excitatory drive to spinal motoneurones is necessary for serotonin to modulate motoneurone excitability via 5-HT(2) receptors in humans. Eur J Neurosci. 2024;59(1):17\u201335. https:\/\/doi.org\/10.1111\/ejn.16190.","journal-title":"Eur J Neurosci"},{"issue":"6","key":"1519_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1113\/jp284164","volume":"601","author":"BI Goodlich","year":"2023","unstructured":"Goodlich BI, Del Vecchio A, Horan SA, Kavanagh JJ. Blockade of 5-HT(2) receptors suppresses motor unit firing and estimates of persistent inward currents during voluntary muscle contraction in humans. J Physiol. 2023;601(6):1121\u201338. https:\/\/doi.org\/10.1113\/jp284164.","journal-title":"J Physiol"},{"issue":"3","key":"1519_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2174\/1874609811104030192","volume":"4","author":"BC Clark","year":"2011","unstructured":"Clark BC, Taylor JL. Age-related changes in motor cortical properties and voluntary activation of skeletal muscle. Curr Aging Sci. 2011;4(3):192\u20139. https:\/\/doi.org\/10.2174\/1874609811104030192.","journal-title":"Curr Aging Sci"},{"issue":"9","key":"1519_CR31","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/gerona\/glv030","volume":"70","author":"BC Clark","year":"2015","unstructured":"Clark BC, Taylor JL, Hong SL, Law TD, Russ DW. Weaker seniors exhibit motor cortex hypoexcitability and impairments in voluntary activation. J Gerontol A Biol Sci Med Sci. 2015;70(9):1112\u20139. https:\/\/doi.org\/10.1093\/gerona\/glv030.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1519_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","volume":"1","author":"S von Haehling","year":"2010","unstructured":"von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129\u201333. https:\/\/doi.org\/10.1007\/s13539-010-0014-2.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P. Men and mice: Relating their ages. Life Sci. 2016;152:244\u20138. https:\/\/doi.org\/10.1016\/j.lfs.2015.10.025.","journal-title":"Life Sci"},{"issue":"6","key":"1519_CR34","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1007\/s11357-014-9726-0","volume":"36","author":"SB Ballak","year":"2014","unstructured":"Ballak SB, Degens H, Bus\u00e9-Pot T, de Haan A, Jaspers RT. Plantaris muscle weakness in old mice: relative contributions of changes in specific force, muscle mass, myofiber cross-sectional area, and number. Age (Dordr). 2014;36(6):9726. https:\/\/doi.org\/10.1007\/s11357-014-9726-0.","journal-title":"Age (Dordr)"},{"issue":"711","key":"1519_CR35","doi-asserted-by":"publisher","first-page":"eabh3489","DOI":"10.1126\/scitranslmed.abh3489","volume":"15","author":"JH Bae","year":"2023","unstructured":"Bae JH, Jo A, Cho SC, et al. Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate. Sci Transl Med. 2023;15(711):eabh3489. https:\/\/doi.org\/10.1126\/scitranslmed.abh3489.","journal-title":"Sci Transl Med"},{"key":"1519_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.03.016","volume":"67","author":"KA Sheth","year":"2018","unstructured":"Sheth KA, Iyer CC, Wier CG, et al. Muscle strength and size are associated with motor unit connectivity in aged mice. Neurobiol Aging. 2018;67:128\u201336. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.03.016.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1519_CR37","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/cells10092459","volume":"10","author":"WG Zhu","year":"2021","unstructured":"Zhu WG, Hibbert JE, Lin KH, et al. Weight pulling: A novel mouse model of human progressive resistance exercise. Cells. 2021;10(9):2459. https:\/\/doi.org\/10.3390\/cells10092459.","journal-title":"Cells."},{"issue":"2","key":"1519_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1152\/japplphysiol.00571.2021","volume":"132","author":"TJ Kelty","year":"2022","unstructured":"Kelty TJ, Mao X, Kerr NR, Childs TE, Ruegsegger GN, Booth FW. Resistance-exercise training attenuates LPS-induced astrocyte remodeling and neuroinflammatory cytokine expression in female Wistar rats. J Appl Physiol (1985). 2022;132(2):317\u201326. https:\/\/doi.org\/10.1152\/japplphysiol.00571.2021.","journal-title":"J Appl Physiol (1985)"},{"issue":"9","key":"1519_CR39","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/glia.24382","volume":"71","author":"N Pukos","year":"2023","unstructured":"Pukos N, Marion CM, Arnold WD, Noble BT, Popovich PG, McTigue DM. Chronic demyelination and myelin repair after spinal cord injury in mice: A potential link for glutamatergic axon activity. Glia. 2023;71(9):2096\u2013116. https:\/\/doi.org\/10.1002\/glia.24382.","journal-title":"Glia"},{"key":"1519_CR40","doi-asserted-by":"publisher","unstructured":"Arnold WD, Sheth KA, Wier CG, Kissel JT, Burghes AH, Kolb SJ. Electrophysiological motor unit number estimation (MUNE) measuring compound muscle action potential (CMAP) in mouse hindlimb muscles. J Vis Exp. 2015;(103). https:\/\/doi.org\/10.3791\/52899.","DOI":"10.3791\/52899"},{"issue":"3","key":"1519_CR41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s11357-021-00369-3","volume":"43","author":"CJ Padilla","year":"2021","unstructured":"Padilla CJ, Harrigan ME, Harris H, et al. Profiling age-related muscle weakness and wasting: neuromuscular junction transmission as a driver of age-related physical decline. Geroscience. 2021;43(3):1265\u201381. https:\/\/doi.org\/10.1007\/s11357-021-00369-3.","journal-title":"Geroscience"},{"key":"1519_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2019.10.022","volume":"86","author":"D Chugh","year":"2020","unstructured":"Chugh D, Iyer CC, Wang X, Bobbili P, Rich MM, Arnold WD. Neuromuscular junction transmission failure is a late phenotype in aging mice. Neurobiol Aging. 2020;86:182\u201390. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.022.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1519_CR43","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1113\/jp270561","volume":"594","author":"RT Hepple","year":"2016","unstructured":"Hepple RT, Rice CL. Innervation and neuromuscular control in ageing skeletal muscle. J Physiol. 2016;594(8):1965\u201378. https:\/\/doi.org\/10.1113\/jp270561.","journal-title":"J Physiol"},{"issue":"2","key":"1519_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1124\/jpet.107.133348","volume":"325","author":"WJ Thomsen","year":"2008","unstructured":"Thomsen WJ, Grottick AJ, Menzaghi F, et al. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther. 2008;325(2):577\u201387. https:\/\/doi.org\/10.1124\/jpet.107.133348.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1519_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/npp.2011.303","volume":"37","author":"GA Higgins","year":"2012","unstructured":"Higgins GA, Silenieks LB, Rossmann A, et al. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology. 2012;37(5):1177\u201391. https:\/\/doi.org\/10.1038\/npp.2011.303.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1519_CR46","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1124\/jpet.111.183525","volume":"338","author":"ED Levin","year":"2011","unstructured":"Levin ED, Johnson JE, Slade S, et al. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats. J Pharmacol Exp Ther. 2011;338(3):890\u20136. https:\/\/doi.org\/10.1124\/jpet.111.183525.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"1519_CR47","first-page":"525","volume":"38","author":"A Gustafson","year":"2013","unstructured":"Gustafson A, King C, Rey JA. Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity. Pharm Ther. 2013;38(9):525\u201334.","journal-title":"Pharm Ther"},{"issue":"1","key":"1519_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1081\/clt-120028749","volume":"42","author":"N Gunja","year":"2004","unstructured":"Gunja N, Collins M, Graudins A. A comparison of the pharmacokinetics of oral and sublingual cyproheptadine. J Toxicol Clin Toxicol. 2004;42(1):79\u201383. https:\/\/doi.org\/10.1081\/clt-120028749.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"12","key":"1519_CR49","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1152\/jn.00386.2014","volume":"112","author":"BC Clark","year":"2014","unstructured":"Clark BC, Mahato NK, Nakazawa M, Law TD, Thomas JS. The power of the mind: the cortex as a critical determinant of muscle strength\/weakness. J Neurophysiol. 2014;112(12):3219\u201326. https:\/\/doi.org\/10.1152\/jn.00386.2014.","journal-title":"J Neurophysiol"},{"issue":"9","key":"1519_CR50","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.exger.2010.04.005","volume":"45","author":"M McGinley","year":"2010","unstructured":"McGinley M, Hoffman RL, Russ DW, Thomas JS, Clark BC. Older adults exhibit more intracortical inhibition and less intracortical facilitation than young adults. Exp Gerontol. 2010;45(9):671\u20138. https:\/\/doi.org\/10.1016\/j.exger.2010.04.005.","journal-title":"Exp Gerontol"},{"issue":"6","key":"1519_CR51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.exger.2011.01.004","volume":"46","author":"JW Noble","year":"2011","unstructured":"Noble JW, Eng JJ, Kokotilo KJ, Boyd LA. Aging effects on the control of grip force magnitude: an fMRI study. Exp Gerontol. 2011;46(6):453\u201361. https:\/\/doi.org\/10.1016\/j.exger.2011.01.004.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1519_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/02701367.2004.10609127","volume":"75","author":"G Kamen","year":"2004","unstructured":"Kamen G. Neural issues in the control of muscular strength. Res Q Exerc Sport. 2004;75(1):3\u20138. https:\/\/doi.org\/10.1080\/02701367.2004.10609127.","journal-title":"Res Q Exerc Sport"},{"issue":"6","key":"1519_CR53","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1152\/jappl.1995.79.6.1908","volume":"79","author":"G Kamen","year":"1995","unstructured":"Kamen G, Sison SV, Du CC, Patten C. Motor unit discharge behavior in older adults during maximal-effort contractions. J Appl Physiol (1985). 1995;79(6):1908\u201313. https:\/\/doi.org\/10.1152\/jappl.1995.79.6.1908.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"1519_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1050-6411(02)00084-6","volume":"13","author":"RM Enoka","year":"2003","unstructured":"Enoka RM, Christou EA, Hunter SK, et al. Mechanisms that contribute to differences in motor performance between young and old adults. J Electromyogr Kinesiol. 2003;13(1):1\u201312. https:\/\/doi.org\/10.1016\/s1050-6411(02)00084-6.","journal-title":"J Electromyogr Kinesiol"},{"issue":"5","key":"1519_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/gerona\/glq012","volume":"65","author":"DJ Clark","year":"2010","unstructured":"Clark DJ, Patten C, Reid KF, Carabello RJ, Phillips EM, Fielding RA. Impaired voluntary neuromuscular activation limits muscle power in mobility-limited older adults. J Gerontol A Biol Sci Med Sci. 2010;65(5):495\u2013502. https:\/\/doi.org\/10.1093\/gerona\/glq012.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"17","key":"1519_CR56","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1113\/jp284603","volume":"601","author":"LBR Orssatto","year":"2023","unstructured":"Orssatto LBR, Blazevich AJ, Trajano GS. Ageing reduces persistent inward current contribution to motor neurone firing: Potential mechanisms and the role of exercise. J Physiol. 2023;601(17):3705\u201316. https:\/\/doi.org\/10.1113\/jp284603.","journal-title":"J Physiol"},{"issue":"4","key":"1519_CR57","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1152\/jn.00698.2020","volume":"125","author":"JR Thorstensen","year":"2021","unstructured":"Thorstensen JR, Taylor JL, Kavanagh JJ. Human corticospinal-motoneuronal output is reduced with 5-HT(2) receptor antagonism. J Neurophysiol. 2021;125(4):1279\u201388. https:\/\/doi.org\/10.1152\/jn.00698.2020.","journal-title":"J Neurophysiol"},{"issue":"23","key":"1519_CR58","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.3390\/jcm10235552","volume":"10","author":"S Giovannini","year":"2021","unstructured":"Giovannini S, Brau F, Forino R, et al. Sarcopenia: Diagnosis and management, state of the art and contribution of ultrasound. J Clin Med. 2021;10(23):5552. https:\/\/doi.org\/10.3390\/jcm10235552.","journal-title":"J Clin Med"},{"issue":"10","key":"1519_CR59","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148\u201361. https:\/\/doi.org\/10.1007\/s12603-018-1139-9.","journal-title":"J Nutr Health Aging"},{"key":"1519_CR60","doi-asserted-by":"publisher","first-page":"5095673","DOI":"10.1155\/2018\/5095673","volume":"2018","author":"G Piastra","year":"2018","unstructured":"Piastra G, Perasso L, Lucarini S, et al. Effects of two types of 9-month adapted physical activity program on muscle mass, muscle strength, and balance in moderate sarcopenic older women. Biomed Res Int. 2018;2018:5095673. https:\/\/doi.org\/10.1155\/2018\/5095673.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1519_CR61","doi-asserted-by":"publisher","first-page":"863","DOI":"10.14336\/ad.2019.1012","volume":"11","author":"W Bao","year":"2020","unstructured":"Bao W, Sun Y, Zhang T, et al. Exercise programs for muscle mass, muscle strength and physical performance in older adults with sarcopenia: a systematic review and meta-analysis. Aging Dis. 2020;11(4):863\u201373. https:\/\/doi.org\/10.14336\/ad.2019.1012.","journal-title":"Aging Dis"},{"issue":"Suppl 1","key":"1519_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ggi.13322","volume":"18","author":"H Arai","year":"2018","unstructured":"Arai H, Wakabayashi H, Yoshimura Y, Yamada M, Kim H, Harada A. Chapter 4 treatment of sarcopenia. Geriatr Gerontol Int. 2018;18(Suppl 1):28\u201344. https:\/\/doi.org\/10.1111\/ggi.13322.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1519_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40981-019-0275-5","volume":"5","author":"J Takata","year":"2019","unstructured":"Takata J, Arashi T, Abe A, Arai S, Haruyama N. Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI). JA Clin Rep. 2019;5(1):55. https:\/\/doi.org\/10.1186\/s40981-019-0275-5.","journal-title":"JA Clin Rep"},{"issue":"4","key":"1519_CR64","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/neurolint13040062","volume":"13","author":"MW Harbell","year":"2021","unstructured":"Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic considerations for patients on psychotropic drug therapies. Neurol Int. 2021;13(4):640\u201358. https:\/\/doi.org\/10.3390\/neurolint13040062.","journal-title":"Neurol Int"},{"issue":"12","key":"1519_CR65","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1808721","volume":"379","author":"EA Bohula","year":"2018","unstructured":"Bohula EA, Wiviott SD, McGuire DK, et al. Cardiovascular safety of lorcaserin in overweight or obese patients. N Engl J Med. 2018;379(12):1107\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1808721.","journal-title":"N Engl J Med"},{"key":"1519_CR66","unstructured":"Medicine USNLo. A study of lorcaserin for the treatment of dravet syndrome. https:\/\/clinicaltrials.gov\/study\/NCT04572243.\u00a0Accessed 19 Aug 2024."},{"key":"1519_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/dmso.S36276","volume":"6","author":"JR Taylor","year":"2013","unstructured":"Taylor JR, Dietrich E, Powell J. Lorcaserin for weight management. Diabetes Metab Syndr Obes. 2013;6:209\u201316. https:\/\/doi.org\/10.2147\/dmso.S36276.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1519_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MCO.0b013e328359efd7","volume":"16","author":"JE Morley","year":"2013","unstructured":"Morley JE. Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care. 2013;16(1):27\u201332. https:\/\/doi.org\/10.1097\/MCO.0b013e328359efd7.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1519_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol. 2024;20(5):261\u201377. https:\/\/doi.org\/10.1038\/s41574-023-00943-z.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"1519_CR70","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/dom.12690","volume":"18","author":"C Apovian","year":"2016","unstructured":"Apovian C, Palmer K, Fain R, Perdomo C, Rubino D. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies. Diabetes Obes Metab. 2016;18(9):945\u20138. https:\/\/doi.org\/10.1111\/dom.12690.","journal-title":"Diabetes Obes Metab"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01519-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01519-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T13:03:02Z","timestamp":1750510982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01519-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01519-7","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the past 5-years, Dr. Clark has received grants from the NIH, NMD Pharma, OsteoDx Inc, and Myolex. He also reports serving as a co-founder and chief of aging research at OsteoDx Inc outside the submitted work. Dr. Arnold has received grant funding from NMD Pharma, Avidity Biosciences, consulting fees from Avidity Biosciences, NMD Pharma, Dyne Therapeutics, Genentech, Design Therapeutics, Catalyst Pharmaceuticals, and Insmed regarding therapeutic development for Duchenne Muscular Dystrophy, Myotonic Dystrophy type 1, and Spinal Muscular Atrophy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors have no conflict of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}